BioSpace News Archive

Press Releases

Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)

May 26, 2025
·
13 min read
Press Releases

Dizal to Highlight its Portfolio Advances in Hematologic Malignancies and Lung Cancer at ASCO 2025

May 26, 2025
·
8 min read
World’s First -- XellSmart’s Allogeneic iPSC-derived Regenerative Cell Therapy for Spinal Cord Injury Officially Approved by the U.S. FDA for a Registrational Phase I Clinical Trial

May 26, 2025
·
6 min read
Press Releases

FDA CBER Director Dr. Vinay Prasad to Keynote NORD’s Inaugural Rare Disease Scientific Symposium, Convening Top Researchers, Industry Leaders, and Federal Regulators

May 26, 2025
·
3 min read
Press Releases

Boundless Bio Announces Portfolio Prioritization and Runway Extension

May 26, 2025
·
8 min read
Press Releases

Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine

May 26, 2025
·
4 min read
Press Releases

Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering

May 26, 2025
·
3 min read
Press Releases

Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025)

May 26, 2025
·
11 min read
Press Releases

Abbisko Therapeutics Receives CDE Approval of Breakthrough Therapy Designation for Irpagratinib (ABSK011) in the Treatment of HCC

May 26, 2025
·
3 min read
Press Releases

CHMP recommends EU approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

May 26, 2025
·
11 min read